Wells Fargo
CLRB icon

Wells Fargo’s Cellectar Biosciences CLRB Stock Holding History

Wells Fargo’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7
Closed -$816 – 6989
2024
Q1 		$816 Buy
7
+5
+250% +$542 ﹤0.01% 6193
2023
Q4 		$166 Hold
2
– – ﹤0.01% 6653
2023
Q3 		$188 Hold
2
– – ﹤0.01% 6601
2023
Q2 		$117 Hold
2
– – ﹤0.01% 6834
2023
Q1 		$80 Hold
2
– – ﹤0.01% 6984
2022
Q4 		$94 Buy
2
+1
+100% +$60 ﹤0.01% 6809
2022
Q3 		$0 Hold
1
– – ﹤0.01% 6725
2022
Q2 		$0 Hold
1
– – ﹤0.01% 6866
2022
Q1 		$0 Hold
1
– – ﹤0.01% 7126
2021
Q4 		$0 Sell
1
-10
-91% -$2.41K ﹤0.01% 7266
2021
Q3 		$3K Hold
11
– – ﹤0.01% 6481
2021
Q2 		$4K Hold
11
– – ﹤0.01% 6388
2021
Q1 		$6K Hold
11
– – ﹤0.01% 6448
2020
Q4 		$6K Buy
11
+1
+10% +$460 ﹤0.01% 6107
2020
Q3 		$4K Hold
10
– – ﹤0.01% 6041
2020
Q2 		$4K Sell
10
-3
-23% -$1.26K ﹤0.01% 6006
2020
Q1 		$5K Buy
+13
New +$8.7K ﹤0.01% 5854
2018
Q3 		– Hold
0
– – – 6393
2018
Q2 		– Hold
0
– – – 6338
2018
Q1 		– Hold
0
– – – 6374
2017
Q4 		– Hold
0
– – – 6359
2017
Q3 		– Hold
0
– – – 6312
2017
Q2 		– Hold
0
– – – 6242
2017
Q1 		– Hold
0
– – – 6313
2016
Q4 		– Hold
0
– – – 6264
2016
Q3 		– Hold
0
– – – 6188
2016
Q2 		– Hold
0
– – – 6114
2016
Q1 		– Hold
0
– – – 6222

Other funds holding CLRB

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo's CLRB Position: Q2 2024 in Review

Wells Fargo sold out of Cellectar Biosciences (CLRB) in Q2 2024, closing a stake of 7 shares — an estimated $816 sold.

Wells Fargo first reported a position in CLRB in Q1 2020 and held it in 17 quarters. The position peaked at $6K in Q1 2021. 37 funds tracked by Wall St. Rank hold CLRB as of Q2 2024.

  • Wells Fargo reported no remaining Cellectar Biosciences position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 7 Cellectar Biosciences shares in Q2 2024, an estimated $816.
  • Wells Fargo first reported a position in Cellectar Biosciences in Q1 2020 and held it in 17 quarters.
  • Wells Fargo's Cellectar Biosciences position peaked at $6K in Q1 2021.
  • 37 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.